Company Ticker News August 16, 2021AcelRx Pharmaceuticals (ACRX) Reports Q2 Loss, Lags Revenue Estimates 0 0 Share
Company Ticker News August 16, 2021AcelRx Pharmaceuticals, Inc. (ACRX) CEO Vincent Angotti on Q2 2021 Results - Earnings Call Transcript 0 0 Share
Company Ticker News August 16, 2021AcelRx Pharmaceuticals Reports Second Quarter 2021 Financial Results 0 0 Share
Press Release August 9, 2021SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AcelRx Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ACRX 0 0 Share
Press Release August 9, 2021DEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm 0 0 Share
Press Release August 9, 2021ACRX Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds AcelRx Pharmaceuticals, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: August 9, 2021 0 0 Share
Press Release August 9, 2021ACRX Final Deadline Today: Rosen, Trusted National Trial Counsel, Encourages AcelRx Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important August 9 Deadline in Securities Class Action - ACRX 0 0 Share
Company Ticker News August 9, 2021AcelRx to Host Second Quarter 2021 Financial Results Call and Webcast on August 16, 2021 0 0 Share
Press Release August 6, 2021ACRX Final Deadline Monday: Rosen, a Trusted and Leading Law Firm, Encourages AcelRx Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 9 Deadline in Securities Class Action - ACRX 0 0 Share
Press Release August 6, 2021DEADLINE MONDAY ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm 0 0 Share
